Cargando…
Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience
PURPOSE: Dimethyl fumarate (DMF) is an oral formulation approved for the treatment of moderate-to-severe psoriasis in adult patients requiring systemic therapy. Here, we describe our clinical experience with DMF for moderate-to-severe psoriasis in Spain. PATIENTS AND METHODS: This is a retrospective...
Autores principales: | Rosés Gibert, Pau, de la Torre Gomar, Francisco Javier, Saenz Aguirre, Amaia, Gimeno Castillo, Javier, González Pérez, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250788/ https://www.ncbi.nlm.nih.gov/pubmed/35791415 http://dx.doi.org/10.2147/PTT.S367060 |
Ejemplares similares
-
Acral lesions in a pediatric population during the COVID-19 pandemic: a case series of 36 patients from a single hospital in Spain
por: Rosés-Gibert, Pau, et al.
Publicado: (2020) -
Paradoxical SAPHO Syndrome after Etanercept in a Patient with Psoriasis
por: Gimeno-Castillo, Javier., et al.
Publicado: (2022) -
Lichen planus after SARS-CoV-2 infection treated with lopinavir/ritonavir()
por: Gimeno Castillo, Javier, et al.
Publicado: (2021) -
Liquen plano en una paciente tras SARS-CoV-2 tratado con lopinavir/ritonavir
por: Gimeno Castillo, Javier, et al.
Publicado: (2021) -
Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
por: Malara, Giovanna, et al.
Publicado: (2021)